Moderna’s mRNA-based mpox vaccine shows promise in trials

Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox. Now, new research from the drug company Moderna suggests its new mpox vaccine, based … Click to Continue »

View original article
Contributor: